AstraZeneca Pharma P/B Ratio
AstraZeneca Pharma (ASTRAZEN) P/B ratio is 28.11 (High), book value per share ₹1540.00 vs Healthcare average P/B of -0.33 — Very High - Significant premium, high growth expectations or speculative. Compare with ASTRAZEN fair value to assess whether the stock is under or overvalued.
Current Valuation Metrics
Book Value Breakdown (2025)
Valuation Signal
Sector Context
ASTRAZEN P/B Ratio — Valuation Insights & Book Value Analysis
AstraZeneca Pharma price-to-book ratio interpretation, valuation status and historical context — current P/B 28.11 (High). View ASTRAZEN annual price range for the annual high/low range and current price position.
- Stock appears overvalued with PB of 28.11, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 530.0% above historical average
- Trading at premium to sector average PB of -0.33
AstraZeneca Pharma P/B Ratio Historical Trend
ASTRAZEN annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. For live price, earnings yield and the full fundamental profile, see AstraZeneca Pharma share price today.
ASTRAZEN Historical P/B Ratio — Book Value Per Share & Year-End Price
AstraZeneca Pharma annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2025 | 5.86 | ₹1540.0 | ₹9029.00 | ₹770 | High |
| 2024 | 5.13 | ₹1424.0 | ₹7305.15 | ₹712 | High |
| 2023 | 4.69 | ₹1178.0 | ₹5526.60 | ₹589 | High |
| 2022 | 3.23 | ₹1022.0 | ₹3297.15 | ₹511 | High |
| 2021 | 3.4 | ₹912.0 | ₹3098.25 | ₹456 | High |
ASTRAZEN vs Healthcare Peers — P/B Ratio Comparison
AstraZeneca Pharma P/B 28.11 vs Healthcare average -0.33, median 0.63 — range -17.92–1.01.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -17.92 | ₹22 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Parmax Pharma | PARMAX | -2.48 | ₹14 | Low |
| Bharat Immunologicals | BIBCL | -2.32 | ₹76 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.71 | ₹127 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.63 | ₹53 | Low |